Derek Saul has covered markets for the Forbes news team since 2021. Danish pharmaceutical giant Novo Nordisk reported the most robust quarterly profits and sales in its history Thursday ...

Sanders opened the hearing by displaying charts comparing Novo Nordisk's prices charged to ... about how insurance conglomerates are taking in record profits or how PBMs are being investigated ...

Eli Lilly's shares jumped to a record high following a better-than-expected earnings report, while ... More shares of Novo Nordisk skyrocketed on the heels of a promising clinical trial.

Wegovy sales continued to soar, recording DKK 17.4 billion in sales, representing a surge of 83%, driven by high prescription rates and Novo Nordisk’s efforts to meet the same. Year to date ...

COPENHAGEN (Reuters) - Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard ... However, Novo's shares have plunged since hitting a record-high in June last year as competition, particularly ...

The stock is up 8.55% over the last year and 7.45% year-to-date. Let’s look at what the charts indicate for Novo Nordisk stock and how the stock maps against Wall Street estimates. Novo Nordisk ...

Novo Nordisk CEO Lars Fruergaard Jørgensen will ... and patent loss (2032). Novo’s record of innovation helped it maintain insulin market leadership over decades, and innovation in GLP-1 ...